Increased T-cell responses to Epstein–Barr virus with high viral load in patients with Epstein–Barr virus-positive diffuse large B-cell lymphoma

References

• Hislop AD, Taylor GS, Sauce D, et al. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 2007;25:587–617.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IRAC; 2008.
   Google Scholar
• Oyama T, Ichimura K, Suzuki R, et al. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 2003;27:16–26.
   PubMed Web of Science ®Google Scholar
• Oyama T, Yamamoto K, Asano N, et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 2007; 13:5124–5132.
   PubMed Web of Science ®Google Scholar
• Angulo R, Fulcher DA. Measurement of Candida-specific blastogenesis: comparison of carboxyfluorescein succinimidyl ester labelling of T cells, thymidine incorporation, and CD69 expression. Cytometry 1998;34:143–151.
   PubMedGoogle Scholar
• Kimura H, Morita M, Yabuta Y, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999;37:132–136.
   PubMed Web of Science ®Google Scholar
• Wherry EJ. T cell exhaustion. Nat Immunol 2011;12:492–499.
   PubMed Web of Science ®Google Scholar
• Guppy AE, Rawlings E, Madrigal JA, et al. A quantitative assay for Epstein-Barr Virus-specific immunity shows interferon-gamma producing CD8 + T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease. Transplantation 2007;84:1534–1539.
   PubMed Web of Science ®Google Scholar
• Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4(+) T cells in immunity to viruses. Nat Rev Immunol 2012;12:136–148.
   PubMed Web of Science ®Google Scholar
• Long HM, Zuo J, Leese AM, et al. CD4 + T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells. Blood 2009;114:807–815.
   PubMed Web of Science ®Google Scholar
• Demachi-Okamura A, Ito Y, Akatsuka Y, et al. Epstein-Barr virus nuclear antigen 1-specific CD4 + T cells directly kill Epstein-Barr virus-carrying natural killer and T cells. Cancer Sci 2008;99:1633–1642.
   PubMed Web of Science ®Google Scholar
• Pender MP, Csurhes PA, Pfluger CM, et al. CD8 + T cells far predominate over CD4 + T cells in healthy immune response to Epstein-Barr virus infected lymphoblastoid cell lines. Blood 2012; 120:5085–5087.
   PubMed Web of Science ®Google Scholar
• Gandhi MK, Lambley E, Burrows J, et al. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clin Cancer Res 2006;12:460–464.
   PubMed Web of Science ®Google Scholar
• Suzuki R, Yamaguchi M, Izutsu K, et al. Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type. Blood 2011;118:6018–6022.
   PubMed Web of Science ®Google Scholar
• Lin JC, Wang WY, Chen KY, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004;350:2461–2470.
   PubMed Web of Science ®Google Scholar
• Dojcinov SD, Venkataraman G, Pittaluga S, et al. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 2011;117:4726–4735.
   PubMed Web of Science ®Google Scholar
• Ouyang Q, Wagner WM, Walter S, et al. An age-related increase in the number of CD8 + T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech Ageing Dev 2003;124:477–485.
   PubMed Web of Science ®Google Scholar
• Khan N, Hislop A, Gudgeon N, et al. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J Immunol 2004;173:7481–7489.
   PubMed Web of Science ®Google Scholar
• Narimatsu H, Ota Y, Kami M, et al. Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients. Ann Oncol 2007;18:122–128.
   PubMed Web of Science ®Google Scholar
• Kanno H, Naka N, Yasunaga Y, et al. Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma: possible role in the development of overt lymphoma in immunocompetent hosts. Am J Pathol 1997;150:349–357.
   PubMed Web of Science ®Google Scholar
• Takegawa S, Jin Z, Nakayama T, et al. Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorder. Cancer Sci 2008;99:296–302.
   PubMed Web of Science ®Google Scholar
• White RE, Ramer PC, Naresh KN, et al. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest 2012;122:1487–1502.
   PubMed Web of Science ®Google Scholar
• Fogg MH, Wirth LJ, Posner M, et al. Decreased EBNA-1-specific CD8 + T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma. Proc Natl Acad Sci USA 2009;106: 3318–3323.
   PubMed Web of Science ®Google Scholar
• Heller KN, Arrey F, Steinherz P, et al. Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1. Int J Cancer 2008;123:2824–2831.
   PubMed Web of Science ®Google Scholar
• Raab-Traub N. Novel mechanisms of EBV-induced oncogenesis. Curr Opin Virol 2012;2:453–458.
   PubMed Web of Science ®Google Scholar
• Long HM, Taylor GS, Rickinson AB. Immune defence against EBV and EBV-associated disease. Curr Opin Immunol 2011;23:258–264.
   PubMed Web of Science ®Google Scholar